RSV/Flu Combination Vaccine Study for Senior Adults

Now Enrolling in Austin and Yukon

Investigational Vaccine Study

Tekton Research is looking for senior adults (65+) to participate in a Paid Investigational Vaccine Study.

You may be eligible to take part if you are:

  • 65 years of age or older
  • Have not received a flu vaccine this year
Apply Now!

RSV/Flu

Respiratory syncytial virus (RSV) can cause infections of the lungs and respiratory tract. Symptoms can be similar to a cold, and may include runny nose, sore throat, cough, and headache. RSV infects about 5% to 10% of residents in long-term facilities each year. Both RSV and influenza (flu) can lead to serious conditions like pneumonia, especially for people age 65+.

While there is currently no approved vaccination to prevent RSV illnesses, scientists are researching an investigational vaccine co-administered in a single dose with an approved influenza vaccine. This is a placebo-controlled study — some participants may only receive a placebo and an approved seasonal flu vaccine.

Why Tekton?

Tekton Research is a clinical research site that conducts clinical studies with the primary focus on improving the quality of life for all.

We work with pharmaceutical and device companies to help bring new and more effective medications to those who need them. We conduct studies with deliberate concentration on knowledge, skills and integrity.

Here at Tekton, our staff ensures that every potential and current study participant is accurately qualified for the most appropriate study based on criteria.

Interested In Signing Up?